Kimberly Vines Ph.D.
Kimberly Vines is a patent attorney with expertise in prosecuting U.S., foreign, and international applications in the areas of polymer and materials science; pharmaceuticals and pharmaceutical formulation; agricultural chemicals and their formulations; organometallic compounds; and biotechnology. She practices all aspects of patent prosecution including non-infringement and invalidity opinions. Her doctoral thesis was directed to the design and synthesis of novel RXR-selective retinoids as breast cancer chemopreventive agents. Her post-doctoral research was directed to the synthesis of natural products such as Epothilone B and Pseudolaric Acid B as well as anti-malarial compounds.
The On-Sale Bar After High Court Helsinn Ruling
IP Law360, January 31, 2019
Further Erosion of Patent Protection for Diagnostics: The Federal Circuit Denies En Banc Rehearing in Ariosa Diagnostics, Inc. v. Sequenom, Inc.
co-author, AIPLA Quarterly Journal, Vol. 44, No. 3, pp. 437-458, Summer 2016
Methyl-substituted conformationally constrained rexinoid agonists for the retinoid X receptors demonstrate improved efficacy for cancer therapy and prevention
Bioorganic & Medicinal Chemistry, 22, 178-85 (2014)
Syntheses of Benzo(b)furna-6-carbonitrile and 6-cyanobenzo(b)furan-2-boronic acid pinacol ester
Synthetic Communications, 43(14), 1974-1979, 2013
Convenient one-pot synthesis of 4-subsituted-2,6-dihalopyridines: valuable building blocks for medicinally active heterocycles
Abstracts of Papers, 240th American Chemistry Society National Meeting, Boston, Mass. (2010)
Progress towards the total synthesis of Pseudolaric acid B: a novel antipneumocystic and antifungal natural product
Abstracts of Papers, 228th American Chemistry Society National Meeting, Philadelphia, Penn., 2004
Total syntheses of Epothilones B and D
Journal of Organic Chemistry, 69(26), 9269-84, 2004
Synthesis of 1-aryl-7-substituted phthalazines as parasite cysteine protease inhibitors
Abstracts of Papers, 225th American Chemistry Society National Meeting, New Orleans, La., 2003
Total synthese of Epothilones B and D amenable to large-scale preparation
Abstracts of Papers, 225th American Chemical Society National Meeting, New Orleans, La., 2003
9cUAB30, an RXR-specific retinoid, and/or Tamoxifen in the prevention of methylnitrosourea-induced mammary cancers
Cancer Letters, 201(1), 17-24, 2003
Conformationally defined retinoic acid analogues
5. Large-scale synthesis and mammary cancer chrmopreventive activity for (2E,4E,6Z,8E)-8-(3',4'-Dihydro-1'(2'H)-napthalen-1'-ylidene)-3,7-dimethyl-2,4,6-octatrienoic Acid (9cUAB30), Journal of Medicinal Chemistry, 46 (17), 3766-69, 2003
Synthesis and breast cancer chemoprevention for UAB30 and analogs, receptor-selective retinoids
Book of Abstracts, 218th American Chemistry Society National Meeging, New Orleans, La., 1999
University of Alabama School of Law
-
Alabama Law Review, Junior Editor (2012-13); Senior Editor (2013-14)
-
Best Paper: Antitrust, May 2012
-
Best Paper: Criminal Law, December 2011
-
Best Paper: Legal Writing, December 2011
University of Alabama
-
Thesis: Design of conformationally defined retinoids: sythesis nuclear receptor binding, and transcriptional activity of derivatives of (9Z)-UAB30
-
Graduate Student of the Year (Chemistry Department), May 2000
University of Alabama
-
Teaching Assistant, General Chemistry, Biochemistrty and Organic Chemistry (1995-2001)
Kimberly's doctoral thesis was directed to the design and synthesis of novel RXR-selective retinoids as breast cancer chemopreventive agents. Her post-doctoral research was directed to the synthesis of natural products such as Epothilone B and Pseudolaric Acid B as well as anti-malarial compounds. Prior to practicing law, she worked as a chemist at several companies in the greater Boston area.
Stites & Harbison, PLLC Lawyers Named to 2025 Best Lawyers® Publications
Stites & Harbison, PLLC is pleased to announce that 97 of its lawyers are included in the 2025 edition of The Best Lawyers in America®. Since it was first published in 1983, Best Lawyers® has become universally regarded as the definitive guide to legal excellence according to the publication. Additionally, 12 Stites & Harbison attorneys are named as “Lawyer of the Year” and 30 attorneys are recognized in Best Lawyers: Ones to Watch® in America, which recognizes attorneys early in their careers for outstanding professional excellence in private practice in the United States.